Your portfolio companies have AI tools. Do they have AI results?
Most don’t. I turn AI spend into EBITDA impact — for PE-backed life sciences, pharma, and MedTech across Europe.
Request a Portfolio AssessmentEvery portfolio company I've assessed had AI tools. None had AI results.
The tools were there. The processes hadn’t changed. 300K+ EUR in recoverable annual capacity was sitting across seven departments — undocumented, unquantified, invisible to the board.
A number for the board.
Not another AI project to manage.
- Tell me which portfolio companies should invest in AI — and which shouldn’t. Done.
- Give me one person who talks to the GM and delivers the result. No escalation.
- Hand me an EBITDA number I can put in front of the IC — and everyone believes it.
That’s what I deliver.
Fractional CAIO, Board Advisor, Speaker.
Fractional Chief AI Officer
Embedded AI leadership for PE-backed life sciences companies. From assessment to implementation to documented results.
Board & Fund Advisory
AI governance, vendor evaluation, EU AI Act compliance, and technology due diligence for operating partners and boards.
Speaking & Workshops
Keynotes, panels, and leadership workshops. For PE summits, offsites, and conferences.
AI that passes the board meeting and the audit.
EU AI Act
Risk classification, documentation, and compliance pathways built into every implementation.
GDPR & MDR
Data protection and medical device regulation alignment from day one.
Human in the Loop
Every AI workflow includes human oversight, escalation paths, and clear accountability.
Audit-Ready
Full documentation trail. BaFin-aligned. Ready for internal audit, external review, or LP reporting.
EU AI Act
Risk classification, documentation, and compliance pathways built into every implementation.
GDPR & MDR
Data protection and medical device regulation alignment from day one.
Human in the Loop
Every AI workflow includes human oversight, escalation paths, and clear accountability.
Audit-Ready
Full documentation trail. BaFin-aligned. Ready for internal audit, external review, or LP reporting.
Recent work
24 use cases. 7 departments. Board-approved roadmap in the same quarter.
Three-day workshop across all functions. Voice documentation, order processing automation, GDPR-compliant knowledge systems — deployed, not just recommended.
300K+ EUR recoverable annual capacity. Quick wins live in month 1.
Seven functions assessed and quantified in EUR. Insurance claims automation, prescription intake workflows, AI-assisted documentation. MDR and GDPR compliant.
Nine years advising C-level leaders on digital transformation — across aerospace, chemicals, telecom, healthcare, and financial services. Then I narrowed the focus to where AI changes the most: regulated industries with high operational density. I've led AI programmes for PE-backed specialty pharma, trained leadership teams across seven departments, and built the workflows myself when no one else would.
Most companies separate AI strategy from AI implementation. I don't.
— Karolyne Hahn, Munich
How can AI advisory help my portfolio?
I analyse your portfolio companies’ specific challenges, identify high-value AI use cases, and develop tailored solutions. Through a “strategy by doing” approach, you don’t get concepts — you get measurable results that show up in the value creation plan. If needed, I enable the portfolio company’s team to continue independently.
What if portfolio companies already have AI tools?
Most do. The problem is rarely the tools — it’s that processes haven’t changed around them. I assess what’s there, check whether existing tools are EU AI Act compliant, identify what’s actually delivering value, what should be replaced, and close the gap between AI spend and AI results.
How is this different from hiring a consulting firm?
No junior team. No 80-page deck before anything happens. I develop the AI strategy not in an ivory tower, but through concrete prototypes and quick wins inside your portfolio companies. One senior person, directly accountable to you — not to a partner at a firm.
What does it cost?
It depends on the format. A portfolio assessment is a fixed fee. Pilots and advisory retainers are monthly. Everything is modular — you start where it makes sense and scale from there. I provide a transparent proposal after an initial conversation. No surprises.
What does “fractional” mean in practice?
I operate as Chief AI Officer for your portfolio on a retained basis. Hands-on when it matters, async support throughout, calls when needed — not a standing calendar invite nobody wants. You get C-level AI leadership focused on EBITDA impact, delivered sustainably and transparently, without the full-time cost.
How long does a typical engagement last?
It depends on where you start. A portfolio-level assessment takes two weeks. A workshop runs one to three days. A pilot engagement runs 90 days. Advisory retainers typically run 6–12 months, rolling — until the results speak for themselves and you no longer need me.
How do you handle regulatory complexity (EU AI Act, GDPR, MDR, DORA)?
Compliance is part of the advisory from the start — not an afterthought. I help portfolio companies and fund teams navigate EU AI Act classification, GDPR data processing requirements, MDR alignment for MedTech, and DORA resilience obligations for financial services. The goal is audit-ready AI that your compliance team and LPs can stand behind.
What is your approach to Responsible AI?
Responsible AI is not an add-on — it’s how I advise. Whether I sit on the advisory board or work directly with the portfolio company, risk classification, transparency, and human oversight are built into every recommendation. This creates trust with boards, regulators, and LPs — and increasingly, it’s a competitive advantage at exit.
See what the assessment could deliver for your portfolio — an interactive AI Opportunity Matrix from a real engagement.
Walk into your next board meeting with a number.
Start with a two-week portfolio assessment. Fixed fee. No obligation to continue. Tell me where you suspect the biggest untapped capacity — and I’ll show you the numbers.
I work with a limited number of portfolios at a time — to stay available when it matters.